advertisement

---

Wang TJ 11

Showing records 1 to 11 | Display all abstracts from Wang TJ

117976 A novel HDAC8 inhibitor H7E exerts retinoprotective effects against glaucomatous injury via ameliorating aberrant Müller glia activation and oxidative stress
Wu LH
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2024; 174: 116538

---

117196 One-year experience with latanoprostene bunod ophthalmic solution 0.024% in clinical practice: A retrospective observational study
Hsueh CM
PLoS ONE 2024; 19: e0307132

---

117976 A novel HDAC8 inhibitor H7E exerts retinoprotective effects against glaucomatous injury via ameliorating aberrant Müller glia activation and oxidative stress
Cheng YW
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2024; 174: 116538

---

117196 One-year experience with latanoprostene bunod ophthalmic solution 0.024% in clinical practice: A retrospective observational study
Tsai CH; Huang JC
PLoS ONE 2024; 19: e0307132

---

117976 A novel HDAC8 inhibitor H7E exerts retinoprotective effects against glaucomatous injury via ameliorating aberrant Müller glia activation and oxidative stress
Lin FL
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2024; 174: 116538

---

117196 One-year experience with latanoprostene bunod ophthalmic solution 0.024% in clinical practice: A retrospective observational study
Lee SH
PLoS ONE 2024; 19: e0307132

---

117976 A novel HDAC8 inhibitor H7E exerts retinoprotective effects against glaucomatous injury via ameliorating aberrant Müller glia activation and oxidative stress
Hsu KC
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2024; 174: 116538

---

117196 One-year experience with latanoprostene bunod ophthalmic solution 0.024% in clinical practice: A retrospective observational study
Wang TJ
PLoS ONE 2024; 19: e0307132

---

117976 A novel HDAC8 inhibitor H7E exerts retinoprotective effects against glaucomatous injury via ameliorating aberrant Müller glia activation and oxidative stress
Wang MH
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2024; 174: 116538

---

117196 One-year experience with latanoprostene bunod ophthalmic solution 0.024% in clinical practice: A retrospective observational study
Guo SP
PLoS ONE 2024; 19: e0307132

---

117976 A novel HDAC8 inhibitor H7E exerts retinoprotective effects against glaucomatous injury via ameliorating aberrant Müller glia activation and oxidative stress
Yen JL; Wang TJ; Lin TE; Liu YC; Huang WJ; Hsiao G
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2024; 174: 116538

---